Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1135

1.

HPV-FASTER: Combined strategies of HPV vaccination and HPV screening towards a one visit for cervical cancer preventive campaigns.

Bosch FX, Robles C.

Salud Publica Mex. 2018 Nov-Dic;60(6):612-616. doi: 10.21149/10171. No abstract available.

PMID:
30699264
2.

Variability in commercial demand for tree saplings affects the probability of introducing exotic forest diseases.

Alonso Chavez V, Gilligan CA, van den Bosch F.

J Appl Ecol. 2019 Jan;56(1):180-189. doi: 10.1111/1365-2664.13242. Epub 2018 Aug 14.

3.

Cannabinoid type-1 receptor blockade restores neurological phenotypes in two models for Down syndrome.

Navarro-Romero A, Vázquez-Oliver A, Gomis-González M, Garzón-Montesinos C, Falcón-Moya R, Pastor A, Martín-García E, Pizarro N, Busquets-Garcia A, Revest JM, Piazza PV, Bosch F, Dierssen M, de la Torre R, Rodríguez-Moreno A, Maldonado R, Ozaita A.

Neurobiol Dis. 2019 Jan 25;125:92-106. doi: 10.1016/j.nbd.2019.01.014. [Epub ahead of print]

PMID:
30685352
4.

Plant Virus Epidemiology: Applications and Prospects for Mathematical Modeling and Analysis to Improve Understanding and Disease Control.

Jeger MJ, Madden LV, van den Bosch F.

Plant Dis. 2018 May;102(5):837-854. doi: 10.1094/PDIS-04-17-0612-FE. Epub 2018 Mar 30.

PMID:
30673389
5.

Facing real-life with direct oral anticoagulants in patients with nonvalvular atrial fibrillation: outcomes from the first observational and prospective study in a Spanish population.

Cerdá M, Cerezo-Manchado JJ, Johansson E, Martínez F, Fernández M, Varela A, Rodríguez S, Bosch F, Santamaría A.

J Comp Eff Res. 2019 Feb;8(3):165-178. doi: 10.2217/cer-2018-0134. Epub 2019 Jan 18.

PMID:
30654626
6.

Safety and activity of ibrutinib in combination with nivolumab in patients with relapsed non-Hodgkin lymphoma or chronic lymphocytic leukaemia: a phase 1/2a study.

Younes A, Brody J, Carpio C, Lopez-Guillermo A, Ben-Yehuda D, Ferhanoglu B, Nagler A, Ozcan M, Avivi I, Bosch F, Caballero Barrigón MD, Hellmann A, Kuss B, Ma DDF, Demirkan F, Yağci M, Horowitz NA, Marlton P, Cordoba R, Wrobel T, Buglio D, Streit M, Hodkinson BP, Schaffer M, Alvarez J, Ceulemans R, Balasubramanian S, de Jong J, Wang SS, Fourneau N, Jurczak W.

Lancet Haematol. 2019 Feb;6(2):e67-e78. doi: 10.1016/S2352-3026(18)30217-5. Epub 2019 Jan 11.

PMID:
30642819
7.

Prognostic Impact of Tumor-Infiltrating Lymphocytes and Neutrophils on Survival of Patients with Upfront Resection of Pancreatic Cancer.

Miksch RC, Schoenberg MB, Weniger M, Bösch F, Ormanns S, Mayer B, Werner J, Bazhin AV, D'Haese JG.

Cancers (Basel). 2019 Jan 3;11(1). pii: E39. doi: 10.3390/cancers11010039.

8.

Immune checkpoint markers in gastroenteropancreatic neuroendocrine neoplasia.

Bösch F, Brüwer K, Altendorf-Hofmann A, Auernhammer CJ, Spitzweg C, Westphalen CB, Boeck S, Schubert-Fritschle G, Werner J, Heinemann V, Kirchner T, Angele M, Knösel T.

Endocr Relat Cancer. 2019 Mar 1;26(3):293-301. doi: 10.1530/ERC-18-0494.

PMID:
30608901
9.

RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients.

Venken K, Jacques P, Mortier C, Labadia ME, Decruy T, Coudenys J, Hoyt K, Wayne AL, Hughes R, Turner M, Van Gassen S, Martens L, Smith D, Harcken C, Wahle J, Wang CT, Verheugen E, Schryvers N, Varkas G, Cypers H, Wittoek R, Piette Y, Gyselbrecht L, Van Calenbergh S, Van den Bosch F, Saeys Y, Nabozny G, Elewaut D.

Nat Commun. 2019 Jan 2;10(1):9. doi: 10.1038/s41467-018-07911-6.

10.

Burden of Human papillomavirus (HPV)-related disease and potential impact of HPV vaccines in the Republic of Korea.

Kim YT, Serrano B, Lee JK, Lee H, Lee SW, Freeman C, Oh JK, Alemany L, Bosch FX, Bruni L.

Papillomavirus Res. 2018 Dec 30;7:26-42. doi: 10.1016/j.pvr.2018.12.002. [Epub ahead of print]

11.

May oral HPV in healthy individuals explain differences in HPV-attributable fractions in oropharyngeal cancer? A systematic review and meta-analysis.

Mena M, Taberna M, Monfil L, Arbyn M, de Sanjosé S, Bosch FX, Alemany L, Bruni L.

J Infect Dis. 2018 Dec 22. doi: 10.1093/infdis/jiy715. [Epub ahead of print]

PMID:
30590684
12.

Sick leave and its predictors in ankylosing spondylitis: long-term results from the Outcome in Ankylosing Spondylitis International Study.

Webers C, Ramiro S, Landewé R, van der Heijde D, van den Bosch F, Dougados M, van Tubergen A, Boonen A.

RMD Open. 2018 Nov 27;4(2):e000766. doi: 10.1136/rmdopen-2018-000766. eCollection 2018.

13.

Postmortem histopathology of electroencephalography and evoked potentials in postanoxic coma.

van Putten MJAM, Jansen C, Tjepkema-Cloostermans MC, Beernink TMJ, Koot R, Bosch F, Beishuizen A, Hofmeijer J.

Resuscitation. 2019 Jan;134:26-32. doi: 10.1016/j.resuscitation.2018.12.007. Epub 2018 Dec 15.

PMID:
30562596
14.

Present challenges in cervical cancer prevention: Answers from cost-effectiveness analyses.

Diaz M, de Sanjosé S, Bosch FX, Bruni L.

Rep Pract Oncol Radiother. 2018 Nov-Dec;23(6):484-494. doi: 10.1016/j.rpor.2018.04.006. Epub 2018 Apr 26. Review.

PMID:
30534011
15.

New bone formation in the intervertebral joint space in spondyloarthritis: An MRI study.

Laloo F, Herregods N, Jaremko JL, Carron P, Elewaut D, Van den Bosch F, Verstraete K, Jans L.

Eur J Radiol. 2018 Dec;109:210-217. doi: 10.1016/j.ejrad.2018.11.007. Epub 2018 Nov 6.

PMID:
30527307
16.

Donor lymphocyte infusion for BK virus hemorrhagic cystitis and nephropathy: a case report.

Ortí G, Iacoboni G, Barba P, Gimeno R, Roldán E, Fox L, Salamero O, Bosch F, Valcárcel D.

Bone Marrow Transplant. 2018 Dec 5. doi: 10.1038/s41409-018-0402-3. [Epub ahead of print] No abstract available.

PMID:
30518978
17.

Poor Sleep in Hospitalized Patients: Are Hospital-Related Factors at Fault?-Reply.

van den Ende ES, Bosch FH, Nanayakkara PWB.

JAMA Intern Med. 2018 Dec 1;178(12):1728-1729. doi: 10.1001/jamainternmed.2018.6159. No abstract available.

PMID:
30508057
18.

Dichotomization of the new revised international prognostic scoring system for a better clinical stratification of patients with myelodysplastic syndromes.

Montoro J, Pomares H, Villacampa G, Merchán B, Molero A, Alonso E, Gallur L, Grau J, Salamero O, Roldán E, Saumell S, Ortega M, Sureda A, Bosch F, Arnan M, Valcárcel D.

Leuk Lymphoma. 2018 Nov 30:1-6. doi: 10.1080/10428194.2018.1542151. [Epub ahead of print]

PMID:
30499738
19.

Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life.

Imkamp M, Lima Passos V, Boonen A, Arends S, Dougados M, Landewé R, Ramiro S, Van den Bosch F, van der Heijde D, Wink FR, Spoorenberg A, van Tubergen A.

RMD Open. 2018 Nov 14;4(2):e000755. doi: 10.1136/rmdopen-2018-000755. eCollection 2018.

20.

Distinct geographic clustering of oncogenic human papillomaviruses multiple infections in cervical cancers: Results from a worldwide cross-sectional study.

Pimenoff VN, Tous S, Benavente Y, Alemany L, Quint W, Bosch FX, Bravo IG, de Sanjosé S.

Int J Cancer. 2018 Nov 2. doi: 10.1002/ijc.31964. [Epub ahead of print]

PMID:
30387873
21.

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial.

Mease P, Coates LC, Helliwell PS, Stanislavchuk M, Rychlewska-Hanczewska A, Dudek A, Abi-Saab W, Tasset C, Meuleners L, Harrison P, Besuyen R, Van der Aa A, Mozaffarian N, Greer JM, Kunder R, Van den Bosch F, Gladman DD.

Lancet. 2018 Dec 1;392(10162):2367-2377. doi: 10.1016/S0140-6736(18)32483-8. Epub 2018 Oct 22.

PMID:
30360969
22.

Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and placebo-controlled trial.

van der Heijde D, Cheng-Chung Wei J, Dougados M, Mease P, Deodhar A, Maksymowych WP, Van den Bosch F, Sieper J, Tomita T, Landewé R, Zhao F, Krishnan E, Adams DH, Pangallo B, Carlier H; COAST-V study group.

Lancet. 2018 Dec 8;392(10163):2441-2451. doi: 10.1016/S0140-6736(18)31946-9. Epub 2018 Oct 22.

PMID:
30360964
23.

Gender differences in trauma, shock and sepsis.

Bösch F, Angele MK, Chaudry IH.

Mil Med Res. 2018 Oct 26;5(1):35. doi: 10.1186/s40779-018-0182-5. Review.

24.

Sampling for disease absence-deriving informed monitoring from epidemic traits.

Bourhis Y, Gottwald TR, Lopez-Ruiz FJ, Patarapuwadol S, van den Bosch F.

J Theor Biol. 2019 Jan 14;461:8-16. doi: 10.1016/j.jtbi.2018.10.038. Epub 2018 Oct 18.

PMID:
30342894
25.

Particles on Demand for Kinetic Theory.

Dorschner B, Bösch F, Karlin IV.

Phys Rev Lett. 2018 Sep 28;121(13):130602. doi: 10.1103/PhysRevLett.121.130602.

PMID:
30312073
26.

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL.

Flinn IW, Hillmen P, Montillo M, Nagy Z, Illés Á, Etienne G, Delgado J, Kuss BJ, Tam CS, Gasztonyi Z, Offner F, Lunin S, Bosch F, Davids MS, Lamanna N, Jaeger U, Ghia P, Cymbalista F, Portell CA, Skarbnik AP, Cashen AF, Weaver DT, Kelly VM, Turnbull B, Stilgenbauer S.

Blood. 2018 Dec 6;132(23):2446-2455. doi: 10.1182/blood-2018-05-850461. Epub 2018 Oct 4.

27.

Surgical treatment of pNET - Experience of a "high-volume" center.

Bösch F, Hofmann K, Coenen M, Pratschke S, Thomas M, Knösel T, Bruns CJ, Guba M, Werner J, Angele MK.

Surg Oncol. 2018 Sep;27(3):409-414. doi: 10.1016/j.suronc.2018.05.027. Epub 2018 May 29.

PMID:
30217295
28.

Clinical and quality of life improvements with golimumab or infliximab in a real-life ankylosing spondylitis population: the QUO-VADIS study.

Van den Bosch F, Flipo RM, Braun J, Vastesaeger N, Kachroo S, Govoni M.

Clin Exp Rheumatol. 2018 Jul 19. [Epub ahead of print]

PMID:
30148434
29.

Posttransplant monomorphic Burkitt's lymphoma: clinical characteristics and outcome of a multicenter series.

Bobillo S, Abrisqueta P, Sánchez-González B, Giné E, Romero S, Alcoceba M, González-Barca E, González de Villambrosía S, Sancho JM, Gómez P, Bento L, Montoro J, Montes S, López A, Bosch F; Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea (GEL/TAMO cooperative group).

Ann Hematol. 2018 Dec;97(12):2417-2424. doi: 10.1007/s00277-018-3473-8. Epub 2018 Aug 16.

PMID:
30116871
30.

AAV9-mediated telomerase activation does not accelerate tumorigenesis in the context of oncogenic K-Ras-induced lung cancer.

Muñoz-Lorente MA, Martínez P, Tejera Á, Whittemore K, Moisés-Silva AC, Bosch F, Blasco MA.

PLoS Genet. 2018 Aug 16;14(8):e1007562. doi: 10.1371/journal.pgen.1007562. eCollection 2018 Aug.

31.

Neuroendocrine tumors of the small intestine causing a desmoplastic reaction of the mesentery are a more aggressive cohort.

Bösch F, Bruewer K, D'Anastasi M, Ilhan H, Knoesel T, Pratschke S, Thomas M, Rentsch M, Guba M, Werner J, Angele MK.

Surgery. 2018 Nov;164(5):1093-1099. doi: 10.1016/j.surg.2018.06.026. Epub 2018 Jul 31.

PMID:
30076029
32.

A case of progressive abdominal angina.

Mosselveld P, van Werkum MH, Menting TP, Pieters AMMJ, Müller METM, Bosch FH.

Neth J Med. 2018 Jul;76(5):255. No abstract available.

33.

Quality and Quantity of Sleep and Factors Associated With Sleep Disturbance in Hospitalized Patients.

Wesselius HM, van den Ende ES, Alsma J, Ter Maaten JC, Schuit SCE, Stassen PM, de Vries OJ, Kaasjager KHAH, Haak HR, van Doormaal FF, Hoogerwerf JJ, Terwee CB, van de Ven PM, Bosch FH, van Someren EJW, Nanayakkara PWB; “Onderzoeks Consortium Acute Geneeskunde” Acute Medicine Research Consortium.

JAMA Intern Med. 2018 Sep 1;178(9):1201-1208. doi: 10.1001/jamainternmed.2018.2669.

PMID:
30014139
34.

Response to: 'The use of dual-energy CT to detect and depict bone marrow oedema in rheumatoid arthritis: is it ready to substitute MRI?' by Wu et al.

Jans L, De Kock I, Herregods N, Verstraete KL, Van den Bosch FE, Carron P, Oei EH, Elewaut D, Jacques P.

Ann Rheum Dis. 2018 Jul 12. pii: annrheumdis-2018-213960. doi: 10.1136/annrheumdis-2018-213960. [Epub ahead of print] No abstract available.

PMID:
30002086
35.

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.

Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, Monsonego J, Muñoz N, Paavonen J, Pitisuttihum P, Ronnett BM, Steben M, Stoler MH, Wheeler CM, Wiley DJ, Perez G, Saah AJ, Luxembourg A, Li S, DiNubile MJ, Wagner M, Velicer C.

Obstet Gynecol. 2018 Aug;132(2):261-270. doi: 10.1097/AOG.0000000000002736.

PMID:
29995724
36.

FGF21 gene therapy as treatment for obesity and insulin resistance.

Jimenez V, Jambrina C, Casana E, Sacristan V, Muñoz S, Darriba S, Rodó J, Mallol C, Garcia M, León X, Marcó S, Ribera A, Elias I, Casellas A, Grass I, Elias G, Ferré T, Motas S, Franckhauser S, Mulero F, Navarro M, Haurigot V, Ruberte J, Bosch F.

EMBO Mol Med. 2018 Aug;10(8). pii: e8791. doi: 10.15252/emmm.201708791.

37.

Point-of-Care Ultrasound for Internal Medicine: An International Perspective.

Ma IWY, Cogliati C, Bosch FH, Tonelli de Oliveira AC, Arienti V, Blans MJ, Chan B, Bhagra A.

South Med J. 2018 Jul;111(7):439-443. doi: 10.14423/SMJ.0000000000000828. No abstract available.

PMID:
29978231
38.

Safety of obinutuzumab alone or combined with chemotherapy for previously untreated or relapsed/refractory chronic lymphocytic leukemia in the phase IIIb GREEN study.

Leblond V, Aktan M, Ferra Coll CM, Dartigeas C, Kisro J, Montillo M, Raposo J, Merot JL, Robson S, Gresko E, Bosch F, Stilgenbauer S, Foà R.

Haematologica. 2018 Nov;103(11):1889-1898. doi: 10.3324/haematol.2017.186387. Epub 2018 Jul 5.

39.

Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trial.

Burmester GR, Kremer JM, Van den Bosch F, Kivitz A, Bessette L, Li Y, Zhou Y, Othman AA, Pangan AL, Camp HS.

Lancet. 2018 Jun 23;391(10139):2503-2512. doi: 10.1016/S0140-6736(18)31115-2. Epub 2018 Jun 18.

PMID:
29908669
40.

Clinical management of psoriatic arthritis.

Van den Bosch F, Coates L.

Lancet. 2018 Jun 2;391(10136):2285-2294. doi: 10.1016/S0140-6736(18)30949-8. Epub 2018 Jun 1. Review.

PMID:
29893227
41.

[Oligometastases of neuroendocrine tumors-extent of surgery].

Bösch F, Werner J, Angele MK, Guba MO.

Chirurg. 2018 Jun 6. doi: 10.1007/s00104-018-0644-z. [Epub ahead of print] Review. German.

PMID:
29876615
42.

Fluid balance-adjusted creatinine at initiation of continuous venovenous hemofiltration and mortality. A post-hoc analysis of a multicenter randomized controlled trial.

Stads S, Schilder L, Nurmohamed SA, Bosch FH, Purmer IM, den Boer SS, Kleppe CG, Vervloet MG, Beishuizen A, Girbes ARJ, Ter Wee PM, Gommers D, Groeneveld ABJ, Oudemans-van Straaten HM; CASH study group.

PLoS One. 2018 Jun 6;13(6):e0197301. doi: 10.1371/journal.pone.0197301. eCollection 2018.

43.

Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLL.

Blanco G, Vardi A, Puiggros A, Gómez-Llonín A, Muro M, Rodríguez-Rivera M, Stalika E, Abella E, Gimeno E, López-Sánchez M, Senín A, Calvo X, Abrisqueta P, Bosch F, Ferrer A, Stamatopoulos K, Espinet B.

Oncoimmunology. 2018 Feb 20;7(6):e1432328. doi: 10.1080/2162402X.2018.1432328. eCollection 2018.

PMID:
29872562
44.

Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA study.

Rodrigues Manica S, Sepriano A, Ramiro S, Pimentel Santos F, Putrik P, Nikiphorou E, Norton S, Molto A, Dougados M, van der Heijde D, Landewé RBM, van den Bosch FE, Boonen A.

Ann Rheum Dis. 2018 Sep;77(9):1303-1310. doi: 10.1136/annrheumdis-2018-213464. Epub 2018 Jun 2.

PMID:
29860232
45.

Measurement properties of the ASAS Health Index: results of a global study in patients with axial and peripheral spondyloarthritis.

Kiltz U, van der Heijde D, Boonen A, Akkoc N, Bautista-Molano W, Burgos-Vargas R, Wei JC, Chiowchanwisawakit P, Dougados M, Duruoz MT, Elzorkany BK, Gaydukova I, Gensler LS, Gilio M, Grazio S, Gu J, Inman RD, Kim TJ, Navarro-Compan V, Marzo-Ortega H, Ozgocmen S, Pimentel Dos Santos F, Schirmer M, Stebbings S, Van den Bosch FE, van Tubergen A, Braun J.

Ann Rheum Dis. 2018 Sep;77(9):1311-1317. doi: 10.1136/annrheumdis-2017-212076. Epub 2018 Jun 1.

46.

High Rate of Drug-Free Remission After Induction Therapy With Golimumab in Early Peripheral Spondyloarthritis.

Carron P, Varkas G, Renson T, Colman R, Elewaut D, Van den Bosch F.

Arthritis Rheumatol. 2018 Nov;70(11):1769-1777. doi: 10.1002/art.40573.

PMID:
29806090
47.

Obinutuzumab plus bendamustine in previously untreated patients with CLL: a subgroup analysis of the GREEN study.

Stilgenbauer S, Leblond V, Foà R, Böttcher S, Ilhan O, Knauf W, Mikuskova E, Renner C, Tausch E, Woszczyk D, Gresko E, Lundberg L, Moore T, Morris T, Robson S, Bosch F.

Leukemia. 2018 Aug;32(8):1778-1786. doi: 10.1038/s41375-018-0146-5. Epub 2018 Apr 27.

48.

Association of Inflammatory Bowel Disease and Acute Anterior Uveitis, but Not Psoriasis, With Disease Duration in Patients With Axial Spondyloarthritis: Results From Two Belgian Nationwide Axial Spondyloarthritis Cohorts.

Varkas G, Vastesaeger N, Cypers H, Colman R, Renson T, Praet LV, Carron P, Raeman F, Devinck M, Gyselbrecht L, Corluy L, Piette Y, Lenaerts J, Thevissen K, Vanneuville B, Bosch FVD, Elewaut D.

Arthritis Rheumatol. 2018 Oct;70(10):1588-1596. doi: 10.1002/art.40551.

PMID:
29740978
49.

RELAx - REstricted versus Liberal positive end-expiratory pressure in patients without ARDS: protocol for a randomized controlled trial.

Algera AG, Pisani L, Bergmans DCJ, den Boer S, de Borgie CAJ, Bosch FH, Bruin K, Cherpanath TG, Determann RM, Dondorp AM, Dongelmans DA, Endeman H, Haringman JJ, Horn J, Juffermans NP, van Meenen DM, van der Meer NJ, Merkus MP, Moeniralam HS, Purmer I, Tuinman PR, Slabbekoorn M, Spronk PE, Vlaar APJ, Gama de Abreu M, Pelosi P, Serpa Neto A, Schultz MJ, Paulus F; RELAx Investigators and the PROVE Network Investigators.

Trials. 2018 May 9;19(1):272. doi: 10.1186/s13063-018-2640-5.

50.

Venetoclax after idelalisib: relevant progress for CLL.

Bosch F, Hallek M.

Blood. 2018 Apr 12;131(15):1632-1633. doi: 10.1182/blood-2018-02-826396. No abstract available.

PMID:
29650729

Supplemental Content

Support Center